Sofinnova Investments’s Protagonist Therapeutics PTGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Hold
2022
Q2
Sell
2022
Q1
$13M Buy
2021
Q4
$16.5M Buy
2021
Q3
$5.28M Sell
2021
Q2
$20.2M Sell
2021
Q1
$17M Buy
2020
Q4
Sell
2020
Q3
$6.99M Buy
2020
Q2
$5.76M Buy